Bio-Rad Laboratories Return on Investment 2010-2024 | BIO
Current and historical return on investment (ROI) values for Bio-Rad Laboratories (BIO) over the last 10 years.
| Bio-Rad Laboratories ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2024-12-31 |
$0.27B |
$7.77B |
3.09% |
| 2024-09-30 |
$0.31B |
$8.69B |
3.31% |
| 2024-06-30 |
$0.33B |
$7.98B |
3.51% |
| 2024-03-31 |
$0.32B |
$10.25B |
3.25% |
| 2023-12-31 |
$0.34B |
$9.94B |
3.37% |
| 2023-09-30 |
$0.36B |
$9.62B |
3.53% |
| 2023-06-30 |
$0.37B |
$9.65B |
3.56% |
| 2023-03-31 |
$0.40B |
$10.96B |
3.84% |
| 2022-12-31 |
$0.48B |
$10.81B |
4.60% |
| 2022-09-30 |
$0.48B |
$9.65B |
4.30% |
| 2022-06-30 |
$0.54B |
$10.12B |
4.31% |
| 2022-03-31 |
$0.55B |
$11.38B |
4.20% |
| 2021-12-31 |
$0.50B |
$13.70B |
3.91% |
| 2021-09-30 |
$0.57B |
$15.34B |
4.80% |
| 2021-06-30 |
$0.52B |
$11.61B |
5.10% |
| 2021-03-31 |
$0.45B |
$10.62B |
4.89% |
| 2020-12-31 |
$0.42B |
$9.89B |
5.21% |
| 2020-09-30 |
$0.30B |
$8.84B |
4.17% |
| 2020-06-30 |
$0.24B |
$7.37B |
3.87% |
| 2020-03-31 |
$0.25B |
$6.31B |
4.18% |
| 2019-12-31 |
$0.23B |
$5.77B |
4.06% |
| 2019-09-30 |
$-0.06B |
$5.57B |
-1.07% |
| 2019-06-30 |
$-0.08B |
$5.92B |
-1.48% |
| 2019-03-31 |
$-0.09B |
$5.30B |
-1.78% |
| 2018-12-31 |
$-0.10B |
$4.46B |
-2.08% |
| 2018-09-30 |
$0.18B |
$5.34B |
3.85% |
| 2018-06-30 |
$0.18B |
$5.08B |
4.40% |
| 2018-03-31 |
$0.14B |
$4.92B |
3.70% |
| 2017-12-31 |
$0.12B |
$3.37B |
3.65% |
| 2017-09-30 |
$0.04B |
$3.28B |
1.32% |
| 2017-06-30 |
$0.03B |
$3.25B |
0.99% |
| 2017-03-31 |
$0.06B |
$3.14B |
1.82% |
| 2016-12-31 |
$0.06B |
$3.01B |
1.84% |
| 2016-09-30 |
$0.14B |
$3.14B |
4.50% |
| 2016-06-30 |
$0.14B |
$3.05B |
4.77% |
| 2016-03-31 |
$0.16B |
$2.98B |
5.47% |
| 2015-12-31 |
$0.17B |
$2.92B |
5.92% |
| 2015-09-30 |
$0.16B |
$2.87B |
5.79% |
| 2015-06-30 |
$0.16B |
$2.80B |
5.93% |
| 2015-03-31 |
$0.16B |
$2.63B |
6.22% |
| 2014-12-31 |
$0.15B |
$2.62B |
5.67% |
| 2014-09-30 |
$0.15B |
$2.61B |
5.70% |
| 2014-06-30 |
$0.15B |
$2.69B |
5.58% |
| 2014-03-31 |
$0.15B |
$2.67B |
5.78% |
| 2013-12-31 |
$0.17B |
$2.62B |
6.29% |
| 2013-09-30 |
$0.19B |
$2.56B |
6.91% |
| 2013-06-30 |
$0.23B |
$2.80B |
8.19% |
| 2013-03-31 |
$0.25B |
$2.76B |
9.10% |
| 2012-12-31 |
$0.26B |
$2.75B |
9.99% |
| 2012-09-30 |
$0.29B |
$2.67B |
11.22% |
| 2012-06-30 |
$0.30B |
$2.59B |
11.81% |
| 2012-03-31 |
$0.29B |
$2.57B |
11.76% |
| 2011-12-31 |
$0.31B |
$2.48B |
12.57% |
| 2011-09-30 |
$0.29B |
$2.43B |
12.09% |
| 2011-06-30 |
$0.29B |
$2.46B |
12.47% |
| 2011-03-31 |
$0.29B |
$2.35B |
13.07% |
| 2010-12-31 |
$0.28B |
$2.27B |
13.35% |
| 2010-09-30 |
$0.26B |
$2.16B |
12.69% |
| 2010-06-30 |
$0.25B |
$2.04B |
12.61% |
| 2010-03-31 |
$0.24B |
$2.04B |
12.27% |
| 2009-12-31 |
$0.23B |
$2.02B |
12.51% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$6.620B |
$2.567B |
|
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.
|
